000 01041 a2200277 4500
005 20250514071438.0
264 0 _c20031014
008 200310s 0 0 eng d
022 _a0272-8087
024 7 _a10.1055/s-2003-39949
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSulkowski, Mark S
245 0 0 _aHepatotoxicity associated with antiretroviral therapy containing HIV-1 protease inhibitors.
_h[electronic resource]
260 _bSeminars in liver disease
_cMay 2003
300 _a183-94 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-HIV Agents
_xadverse effects
650 0 4 _aAntiretroviral Therapy, Highly Active
_xadverse effects
650 0 4 _aHIV Protease Inhibitors
_xadverse effects
650 0 4 _aHepatitis B
650 0 4 _aHepatitis C
_xcomplications
650 0 4 _aHumans
650 0 4 _aLiver
_xdrug effects
773 0 _tSeminars in liver disease
_gvol. 23
_gno. 2
_gp. 183-94
856 4 0 _uhttps://doi.org/10.1055/s-2003-39949
_zAvailable from publisher's website
999 _c12584586
_d12584586